Position Papers and Guidelines
Below are all of ABCD’s position statements since year 2000. Some are dated and have been superseded but nevertheless they remain available as a record of the evolution of thinking in our speciality with time. It is the responsibility of the reader to ensure that any data that they use from these statements has not been superseded by new information / guidance.
Click the link on the left to see the position paper and on the right please find where the paper was published.
| Year / Title | Where published |
| 2021 | |
|
Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement |
https://bjd-abcd.com/index.php/bjd/article/view/711 |
| https://bjd-abcd.com/index.php/bjd/article/view/703 | |
|
Association of British Clinical Diabetologists ABCD website - see link opposite. |
|
|
ABCD and Renal Association Guidelines on the detection and management of diabetes post solid organ transplantation |
|
|
2021 Update Association of British Clinical Diabetologists ABCD website - see link opposite. |
|
|
2021 Update Association of British Clinical Diabetologists ABCD website - see link opposite. |
|
|
2021 Update Association of British Clinical Diabetologists ABCD website - see link opposite. |
|
| 2020 | |
| Post transplant related Diabetes -NEW guideline LAUNCH | Summary document |
| ABCD position statement on standards of care for management of adults with type 1 diabetes | |
| Managing Frailty and Associated Comorbidities in Older Adults with Diabetes | |
| 2019 | |
| Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS) | https://bjd-abcd.com/index.php/bjd/article/view/453 |
| Use of SGLT-2 inhibitors in the treatment of type 1 diabetes | https://bjd-abcd.com/index.php/bjd/article/view/447 |
| 2018 | |
|
As part of the ABCD Renal Association clinical specialty work programme we have now finalised our guidelines on managing hyperglycaemia in kidney disease - See Link Opposite . A summary of the full guidelines with audit standards and issues for future research will be appearing this month in the British Journal of Diabetes. Full Document Peter Winocour, Stephen C Bain,Tahseen A Chowdhury, Parijat De, Ana Pokrajac, Damian Fogarty, Andrew Frankel, Debasish Banerjee, Mona Wahba, Indranil Dasgupta. |
|
| 2017 | |
| Association of British Clinical Diabetologists and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease | Association of British Clinical Diabetologists ABCD website - see link opposite. For a summary of recommendations click here. See also I Dasgupta, DBanerjee, TA Chowdhury, P De, M Wahba, S Bain, A Frankel, D Fogarty, A Pokrajac, PH Winocour. Br. J. Diabetes 2017:17:160-164 |
| Association of British Clinical Diabetologists - Renal Association (ABCD-RA) Clinical Practice Guidelines for Management of Lipids in Adults with Diabetes Mellitus and Nephropathy and/or Chronic Kidney Disease | Association of British Clinical Diabetologists ABCD website - see link opposite. See also PB Mark, PH Winocour, C Day. Br. J. Diabetes 2017;17:64-72. A data collection chart for audit of lipid management can be downloaded by clicking here. |
| 2016 | |
| ABCD position statement on the risk of diabetic ketoacidosis with the use of sodium-glucose cotransporter-2 inhibitors | Association of British Clinical Diabetologists ABCD website - see link opposite. |
| ABCD position statement on standards of care for management of adults with type 1 diabetes - this has been superseded by the 2017 version - see above | Association of British Clinical Diabetologists ABCD website - see link opposite. |
| 2015 | |
| Care coordination/ management for adults with type 1 diabetes - joint position statement with Diabetes UK | Association of British Clinical Diabetologists ABCD website - see link opposite. |
| 2013 | |
| ABCD position statement on GLP-1 based therapies and pancreatic damage - full statement | Association of British Clinical Diabetologists ABCD website - see link opposite. Also published as: REJ Ryder, JA McKnight, AD Blann, K Dhatariya, R Gregory, AM Robinson, S Rowles, P Sharp. PH Winocour, C Walton Practical Diabetes 2013; 30(9): 388-391 |
| ABCD position statement on GLP-1 based therapies and pancreatic damage - summary statement | Association of British Clinical Diabetologists ABCD website - see link opposite |
| ABCD response to the Future Hospital Commission | Association of British Clinical Diabetologists ABCD website - see link opposite |
| 2012 | |
| Type 1 diabetes and specialist care | P Sharp and C Walton Practical Diabetes 2012; 29(8): 1-2 |
| 2011 | |
| Diabetes and end of life care | S Rowles, A Kilvert, A Sinclair Pract Diab Int 2011; 28(1): 26-27 |
| 2010 | |
| Recommendations following suspension of rosiglitazone (Avandia) | N Goenka, A Roberts, S Rowles, REJ Ryder, PH Winocour Pract Diab Int 2010; 27(9): 374-376a |
| Management of hypogonadal males with type 2 diabetes | K Dhatariya, D Nagi, TH Jones Pract Diab Int 2010; 27(9): 408-412 |
| Haemoglobin A1c for the diagnosis of diabetes | ES Kilpatrick and PH Winocour Pract Diab Int 2010; 27(7): 306-310 |
| Physical activity and exercise in diabetes | D Nagi and I Gallen Pract Diab Int 2010; 27(4): 158-163a |
| Continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care | PJ Hammond, SA Amiel, CM Dayan, D Kerr, JC Pickup, JAM Shaw, FM Campbell, SA Greene and PC Hindmarsh Pract Diab Int 2010; 27(2): 66-68 |
| 2009 | |
| Incretin mimetics and DPP-4 inhibitors | CMB Edwards and PH Winocour Pract Diab Int 2009; 26(5): 191-194 |
| Influenza Pandemic (including Swine Flu) and Diabetes | K Shaw. Contingency planning and medical management : implications & implementation considerations for the UK. Published only on this website |
| 2007 | |
| Lipid modifying drug therapy in diabetes | MD Feher and PH Winocour Pract Diab Int 2007; 24(9): 458-462 |
| Screening for gestational diabetes mellitus | S Robinson and A Dornhorst Pract Diab Int 2007; 24(4): 192-195 |
| 2006 | |
| ABCD Diabetes Specialist Surveys | P Winocour et al Various places - see link |
| Insulin pumps | P Hammond, S Boardman and RH Greenwood Pract Diab Int 2006; 23(9): 235-400 |
| Management of hyperglycaemic emergencies in adults | MW Savage and A Kilvert Pract Diab Int 2006; 23(5): 227-231 Diabetic ketoacidosis guideline updated in 2010 - see link |
| 2005 | |
| Joint Position Statement on Access to high quality care for people with diabetes - Diabetes UK and ABCD | Association of British Clinical Diabetologists and Diabetes UK ABCD website - see link |
| 2004 | |
| Diabetic retinal screening following publication of the NSF for England and Wales | C Walton, A Kilvert, REJ Ryder, S Olcak, D Nagi and A Robinson Pract Diab Int 2004; 21(9): 349-351 |
| Glitazones | ER Higgs, AJ Krentz Pract Diab Int 2004; 21(8): 293-295 |
| ABCD position papers: introduction | RH Greenwood, K Shaw, Peter Winocour Pract Diab Int 2004; 21(8): 293-293 |
| Will NICE guidelines on the management of Type 2 diabetes improve diabetes care? | PH Winocour, K Shaw, RH Greenwood Pract Diab Int 2004; 21(1): 3-6 |
| 2002 | |
| National Service Framework (NSF) Standards | PH Winocour, RH Greenwood and J Wales ABCD website - see link |
| General practitioners with a special interest in diabetes | RH Greenwood ABCD website - see link |
| 2000 | |
| ABCD Diabetes Specialist Surveys | P Winocour et al Various places - see link |
Information for HCPs
ABCD Webinar Series
